Similar articles

• Acute neuromuscular weakness in the intensive care unit.

  Maramattom BV, Wijdicks EF. Maramattom BV, et al. Crit Care Med. 2006 Nov;34(11):2835-41. doi: 10.1097/01.CCM.0000239436.63452.81. Crit Care Med. 2006. PMID: 16932235 Review.
• [Neuromuscular manifestations in critically ill patients].

  Smith TA, Fabricius ME. Smith TA, et al. Ugeskr Laeger. 2007 Jun 4;169(23):2216-9. Ugeskr Laeger. 2007. PMID: 17592690 Danish.
• Pharmacology of neuromuscular blocking agents in the intensive care unit.

  Hanson CW 3rd. Hanson CW 3rd. Crit Care Clin. 1994 Oct;10(4):779-97. Crit Care Clin. 1994. PMID: 8000926 Review.
• Use of neuromuscular blocking drugs in the critically ill patient.

  Coursin DB, Prielipp RC. Coursin DB, et al. Crit Care Clin. 1995 Oct;11(4):957-81. Crit Care Clin. 1995. PMID: 8535988 Review.
• A review of neuromuscular blockade in the critically ill patient.

  Burry L, HoSang M, Hynes-Gay P. Burry L, et al. Dynamics. 2001 Fall;12(3):28-33; quiz 34-5. Dynamics. 2001. PMID: 11982205 Review.